MET
About
Location: 7q31.2
Mappings
Biomarkers
MET is involved in the following curated biomarkers.| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| MET Exon 14 (Splice Site) | Somatic Variant | 2 | 5 |
| MET Exon 14 (Deletion) | Somatic Variant | 2 | 5 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Capmatinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Capmatinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Capmatinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Capmatinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib |